Biomedical Science Letters (대한의생명과학회지)

The Korean Society for Biomedical Laboratory Sciences (대한의생명과학회)
권호 표지

Effects of Benzene, Phenol and Hydroquinone on Proliferation, Differentiation and Migration of Human Eosinophilic EoL-1 Cells

  • Moon, So-Hee (Department of Biomedical Laboratory Science, School of Medicine, Eulji University and Eulji University Medical Sciences Research Center) ;
  • Yang, Eun-Ju (Department of Biomedical Laboratory Science, School of Medicine, Eulji University and Eulji University Medical Sciences Research Center) ;
  • Song, Bo-Bae (Department of Biomedical Laboratory Science, School of Medicine, Eulji University and Eulji University Medical Sciences Research Center) ;
  • Kim, Bo-Mi (Department of Biomedical Laboratory Science, School of Medicine, Eulji University and Eulji University Medical Sciences Research Center) ;
  • Lee, Ji-Sook (Department of Clinical Laboratory Science, Wonkwang Health Science University) ;
  • Kim, In-Sik (Department of Biomedical Laboratory Science, School of Medicine, Eulji University and Eulji University Medical Sciences Research Center)
  • Received : 2010.08.23
  • Accepted : 2010.09.17
  • Published : 2010.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Benzene is known as a ubiquitous air pollutant and has a carcinogenic influence on the human body. Benzene is also metabolized to other volatile organic compounds (VOCs) in the body such as phenol and hydroquinone (HQ). The metabolites are accumulated and further oxidized by myeloperoxidase in bone marrow. They act as toxic agents and cause a variety of diseases, including cancer, atopic dermatitis and asthma. In this study, we examined the effects of benzene and its metabolites on proliferation, differentiation and chemotaxis of EoL-1 cells, the human eosinophilic leukemia cell line. These chemicals had no effect on the proliferation of EoL-1 cells. Benzene decreased the differentiation of EoL-1 cells induced by butyric acid. HQ was induced the cell death during butyric acid-induced EoL-1 cell differentiation. In a chemotaxis experiment, benzene, phenol and HQ enhanced the cell migration induced by Lkn-1 but not by MCP-1, eotaxin, MIP-$1{\alpha}$ and RANTES. These findings provide the effect of VOCs on the regulation of eosinophil-involved immune response.

Keywords

References

  1. Arakelyan A, Kriegova E, Kubistova Z, Mrazek F, Kverka M, du Bois RM, Kolek V, Petrek M. Protein levels of CC chemokine ligand (CCL) 15, CCL16 and macrophage stimulating protein in patients with sarcoidosis. Clin Exp Immimol. 2009. 155: 457-465. https://doi.org/10.1111/j.1365-2249.2008.03832.x
  2. Bernstein JA, Alexis N, Bacchus H, Bernstein lL, Fritz P, Horner E, Li N, Mason S, Nel A, Oullette J, Reijula K, Reponen T, Seltzer J, Smith A, Tarlo SM. The health effects of nonindustrial indoor air pollution. J allergy Clin Immunol. 2008. 121: 585-591. https://doi.org/10.1016/j.jaci.2007.10.045
  3. Broxmeyer HE. Regulation of hematopoiesis by chemokine family members. Int J Hematol. 2001. 74: 9-17. https://doi.org/10.1007/BF02982544
  4. Coulin F, Power CA, Alouani S, Peitsch MC, Schroeder JM, Moshizuki M, Clark-Lewis I, Wells TN. Characterisation of macrophage inflammatory protein-5/human CC cytokine-2, a member of the macrophage-inflammatory-protein family of chemokines. Eur J Biochem. 1997. 248: 507-515. https://doi.org/10.1111/j.1432-1033.1997.00507.x
  5. Elsner J, Kapp A. Regulation and modulation of eosinophil effector functions. Allergy. 1999.54: 15-26. https://doi.org/10.1111/j.1398-9995.1999.tb05018.x
  6. Golding BT, Watson WP. Possible mechanisms of carcinogenesis after exposure to benzene. IARC Scientific Pub. 1999. 150: 75-88.
  7. Gotlib J, Cools J, Malone JM, Schrier SL, Gilliland DG, Coutre SE. The FIP1Ll-PDGFR alpha fusion tyrosine kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia: implications for diagnosis, classification, and management. Blood 2004. 103: 2879-2891. https://doi.org/10.1182/blood-2003-06-1824
  8. Haringman JJ, Smeets TJ, Reinders-Blankert P, Tak PP. Chemokine and chemokine receptor expression in paired peripheral blood mononuclear cells and synovial tissue of patients with rheumatoid arthritis, osteoarthritis, and reactive arthritis. Ann Rheum Dis. 2006. 65: 294-300. https://doi.org/10.1136/ard.2005.037176
  9. Ishihara K, Takahashi A, Kaneko M, Sugeno H, Hirasawa N, Hong JJ, Zee OP, Ohuchi K. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors. Life Sci. 2007. 80: 1213-1220. https://doi.org/10.1016/j.lfs.2006.12.016
  10. Kolachana P, Subrahmanyam VV, Meyer KB, Zhang L, Smith MT. Benzene and its phenolic metabolites produce oxidative DNA damage in HL60 cells in vitro and in the bone marrow in vivo. Cancer Res. 1993. 53: 1023-1026.
  11. Lee MH, Chung SW, Kang BY, Kim KM, Kim TS. Hydroquinone, a reactive metabolite of benzene, enhances interleukin4 production in $CD4^+$ T cells and increases immunoglobulin E levels in antigen-primed mice. Immunology. 2002. 106: 496-502. https://doi.org/10.1046/j.1365-2567.2002.01451.x
  12. Lee JS, Kim IS. Leukotactin-1/CCL15 induces cell migration and differentiation of human eosinophilic leukemia EoL-1 cells through $PKC\delta$ activation. Mol Bioi Rep. 2010. 37: 2149-2156. https://doi.org/10.1007/s11033-009-9687-z
  13. Lee JS, Yang EJ, Kim IS. The roles of MCP-1 and protein kinase C delta activation in human eosinophilic leukemia EoL-1 cells. Cytokine 2009. 48: 186-195. https://doi.org/10.1016/j.cyto.2009.07.008
  14. Li Q, Aubrey MT, Christian T, Freed BM. Differential inhibition of DNA synthesis in human T cells by the cigarette tar components hydroquinone and catechol. Fundam Appl Toxicol. 1997.38: 148-165. https://doi.org/10.1006/faat.1997.2329
  15. Macedo, SM, Lourenco EL, Borelli P, Fock RA, Ferreira JM Jr, Farsky SH. Effect of in vivo phenol or hydroquinone exposure on events related to neutrophil delivery during an inflammation response. Toxicology 2006. 220: 126-135. https://doi.org/10.1016/j.tox.2005.12.008
  16. Mayumi M. EoL-1, a human eosinophilic cell line. Leuk Lymphoma. 1992. 7: 243-250. https://doi.org/10.3109/10428199209053629
  17. Rothenberg NL, Hogan SP. The eosinophil. Annu Rev Imunol. 2006. 24: 147-174. https://doi.org/10.1146/annurev.immunol.24.021605.090720
  18. Saito H, Bourinbaiar A, Ginsburg M, Minato K, Ceresi E, Yamada K, Machover D, Breard J, Mathe G. Establishment and characterization of a new human eosinophilic leukemia cell line. Blood 1985. 66: 1233-1240.
  19. Schlosser MJ, Kalf GF. Metabolic activation of hydroquinone by macrophage peroxidase. Chem Bioi Interact. 1989. 72: 191-207. https://doi.org/10.1016/0009-2797(89)90027-6
  20. Schrenk D, Orzechowski A, Snyder R, Burchell B, Ingelman-Sundberg M, Bock KW. Phase II metabolism of benzene. Environ Health Perspect. 1996. 104: 1183-1188. https://doi.org/10.1289/ehp.961041183
  21. Synder R. Benzene and leukemia. Crit Rev Toxicol. 2002. 32: 155-210. https://doi.org/10.1080/20024091064219
  22. Teran LM. CCL chemokines and asthma. Immunol Today. 2000. 21: 235-242. https://doi.org/10.1016/S0167-5699(00)01634-0
  23. Weller PF. The immunobiology of eosinophils. N Engl J Med. 1991. 324: 1110-1118. https://doi.org/10.1056/NEJM199104183241607
  24. Wong EK, Ho CY, Lam CWK, Zhang JP, Hjelm NM. Differentiation of a human eosinophilic leukemic cell line, EoL-1: characterization by the expression of cytokine receptors, adhesion molecules, CD95 and eosinophilic cationic protein (ECP). Immunol Lett. 1999. 68: 317-323. https://doi.org/10.1016/S0165-2478(99)00064-4
  25. Youn BS, Zhang SM, Lee EK, Park DN, Broxmeyer HE, Murphy PM, Locati M, Pease JE, Kim KK, Antol K, Kwon BS. Molecular cloning of leukotactin-1: a novel monocytes and lymphocytes, and a potent agonist at CC chemokine receptors 1 and 3. J Immunol. 1997. 159: 5201-5205.